IDIBELL celebrates a new edition of the Accelerator Meeting Point

  • On this day, IDIBELL researchers who seek to transfer their ideas to the market will present their projects.
  • With several talks on the tools needed to start a business in the biotech sector, IDIBELL’s Innovation and Competitive Projects services will also be presented.
AMP 2024 1080x1080

On April 24, the IDIBELL’s Accelerator Meeting Point (AMP) 5th edition will be held, organized by the Business Development and Innovation Area and the Department of Competitive Calls of the Institute. In this event, innovative projects from the biotech and biomedical sector looking for market transfer resources will be presented. At the same time, investors and leading companies in the healthcare sector will be offered exclusive access to innovation projects at different development stages. All this will be complemented with talks that will bring light and tools to face the innovation process. More information will also be given on the major expansion project of the Bellvitge Campus for the coming years, the Health Biocluster.

This year, the event will consist of three sections: first, IDIBELL’s main researchers will present their projects in pitch deck format. After a short time of coffee and networking, there will be a round table on Horizon Europe calls by the IDIBELL Competitive Projects unit, in addition to a talk on regulatory strategies by Asphalion Iberia. In the third section, Laia Traveset, director of IDIBELL’s innovation unit, will explain what kind of support they offer to researchers, and then the doctor in molecular biology and specialist in biomedical knowledge transfer Luis Ruiz Ávila will lead the plenary. Then, L’Hospitalet City Council will present the Health Biocluster and, to finish, Miguel Angel Souto as the IDIBELL innovation and business development area director will close the day.



The Bellvitge Biomedical Research Institute (IDIBELL) is a biomedical research center created in 2004. It is participated by the Bellvitge University Hospital and the Viladecans Hospital of the Catalan Institute of Health, the Catalan Institute of Oncology, the University of Barcelona and the City Council of L’Hospitalet de Llobregat.

IDIBELL is a member of the Campus of International Excellence of the University of Barcelona HUBc and is part of the CERCA institution of the Generalitat de Catalunya. In 2009 it became one of the first five Spanish research centers accredited as a health research institute by the Carlos III Health Institute. In addition, it is part of the “HR Excellence in Research” program of the European Union and is a member of EATRIS and REGIC. Since 2018, IDIBELL has been an Accredited Center of the AECC Scientific Foundation (FCAECC).

Scroll to Top